Jena E Moseman

7PUBLICATIONS
13CO-AUTHORS
Radiation therapyCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsGene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jun 19, 2026
Activation of tumor-specific CD8+ T cells prior to radiopharmaceutical therapy improves antitumor response.

|Sep 27, 2025
Messenger RNA and Plasmid DNA Vaccines for the Treatment of Cancer.

Jena E Moseman, Daeun Shim, Donghwan Jeon

|Sep 27, 2025
CD8+ T Cells Primed by Antigenic Peptide-Pulsed B Cells or Dendritic Cells Generate Similar Anti-Tumor Response.

Ichwaku Rastogi, Wanyi Guo, Jena E Moseman

|May 09, 2025
PD-1 blockade employed at the time CD8+ T cells are activated enhances their antitumor efficacy.

Jena E Moseman, Ichwaku Rastogi, Donghwan Jeon

|Apr 09, 2025
β-amino acid substitution in the SIINFEKL antigen alters immunological recognition.

Ichwaku Rastogi, John A Mannone, Ruslan Gibadullin

|May 03, 2024
Combining toll-like receptor agonists with immune checkpoint blockade affects antitumor vaccine efficacy.

Donghwan Jeon, Ethan Hill, Jena E Moseman

Pageof 2

Frequent Collaborators

6 joint publications

Douglas G McNeel

4 joint publications

Ichwaku Rastogi

1 joint publications

Aarohi Thakkar

1 joint publications

Amanda R Campbell